scarletred
  • Home
  • Company
  • Products
    Scarletred®Vision
    Scarletred®Telemedicine
  • Services
  • Applications
  • News
  • Contact
Menu
01
Home
02
Company
03
Products
04
Services
05
Applications
06
News
07
Contact
Get in touch
Austria
SCARLETRED Holding GmbH
MQM 3.4, Maria Jacobi Gasse 1,
8th floor, 1030 Vienna, Austria
USA
SCARLETRED Inc.
1 Broadway, 14th floor,
Cambridge, MA 02142, USA
office@scarletred.com
Privacy Policy
Social
Linkedin
Linkedin
Linkedin
Twitter
Instagram
Instagram
Facebook
Facebook
info
Press
Career
FAQ
Regulatory
Imprint

Erythema

Keywords:
#
AAD 2023
#
BioJapan2022
#
JAK inhibitors
#
Safety monitoring
#
GlobalFemaleLeaders
#
GFL
#
EWMD
Scarletred Ivermectin treatment in rosacea patients with Universitätsklinik Tübingen
News
•
Nov 27, 2022

New Publication: Ivermectin Treatment in Rosacea

Discover our newest publication about Ivermectin treatment in rosacea patients in cooperation with the university clinic Tübingen, Germany, and how Scarletred®Vision helped monitor signs and symptoms. 
SCarletred Ivermectin treatment in rosacea patients with Universitätsklinik Tübingen
Article
•
Nov 15, 2022

New Publication: Ivermectin Treatment in Rosacea

Discover our newest publication about Ivermectin treatment in rosacea patients in cooperation with the university clinic Tübingen, Germany, and how Scarletred®Vision helped monitor signs and symptoms. 
Publication
•
September 27, 2021

The mathematics of erythema: Development of machine learning models for artificial intelligence assisted measurement and severity scoring of radiation induced dermatitis

Read more
Find us
  • SCARLETRED Holding GmbH 
    MQM 3.4, Maria Jacobi Gasse 1, 8th floor, 1030 Vienna, Austria
    ‍
    SCARLETRED Inc.
    1 Broadway, 14th floor,
    Cambridge, MA 02142, USA
About us
  • Company
  • Products
  • Services
  • Applications
  • News
Contact us
  • Press
  • Career
  • FAQ
  • Regulatory
  • Contact
Request a demo
Sign in
© 2021 SCARLETRED Holding GmbH
Home
Contact
Imprint
Terms and Conditions